Tony Gao's timing was, if nothing else, fortunate. Or perhaps calculated.
In late May, just weeks after federal regulators voted to advance a ban on Chinese and Hong Kong certification labs for U.S. electronics, Gao's San Francisco startup emerged from Y Combinator with a pitch that suddenly felt prescient: use AI agents to help hardware companies navigate the regulatory maze faster. The company, now called Fuchsia—it launched barely three months earlier under the name Noetic—is wagering that artificial intelligence can help manufacturers weather what could become one of the messiest supply chain disruptions in recent memory.
The stakes are considerable. The Federal Communications Commission's April 30 vote, if it survives the comment period and becomes final rule, would effectively bar U.S. electronics manufacturers from using the low-cost overseas labs where roughly three-quarters of devices are currently tested. That's not a minor hiccup. Chinese facilities charge between $400 and $1,300 per certification, according to Fuchsia's own analysis. U.S. labs? They want $3,000 to $4,000. Multiply that across product lines, and the arithmetic gets uncomfortable quickly.
Which is where Fuchsia comes in—positioning itself as what insiders have started calling "Vanta for hardware," automating the tedious documentation grind that stands between a prototype and a compliant product.
The platform works, in theory, like this: AI "research agents" (the company's term) map a given device to the applicable standards—FCC radio rules, European CE marking, FDA clearances for medical devices, UL safety specs, ISO 9001 quality systems, the whole alphabet soup. The system then drafts the technical files and test plans that accredited labs demand, work that typically consumes weeks of back-and-forth between engineers, regulatory consultants, and lawyers. From there, Fuchsia routes products to partner labs and tracks everything—requirements, drafts, test schedules, approvals—in a single dashboard.
It's a tidy vision. Whether it holds up under the pressure of a suddenly capacity-constrained domestic testing industry is another question entirely.
Fuchsia insists its AI agents keep the process "accurate, timely, and fully traceable," with human experts signing off before anything reaches a lab. The company's Launch YC materials emphasize transparency—no inflated billable hours, full visibility into the workflow. But the proof, as ever, will be in execution. No client names appear on Fuchsia's site yet, though the company notes its team has "certified products for Amazon, Apple, Walmart" in previous roles. (The current team, according to Y Combinator's directory, numbers three.)
The broader market they're chasing is enormous, if not exactly nimble. The global testing, inspection, and certification industry—dominated by giants like UL Solutions, TÜV SÜD, Intertek, and SGS—was valued at $417.8 billion last year and is projected to reach $555.9 billion by 2033, per Grand View Research. The U.S. slice alone could grow from roughly $38 billion to $45 billion by 2031. Yet for all that scale, the workflows remain stubbornly manual and opaque, the kind of inefficiency that venture capitalists love to target.
And they are targeting it. Fuchsia isn't the only Y Combinator company angling for this space. Two other recent batches produced startups—Normal and Saphira—with strikingly similar "Vanta for hardware" framing. That clustering isn't coincidental. It suggests VCs smell an opening, perhaps as regulatory complexity mounts and hardware founders demand better tools to manage it.
Gao, who studied math and physics at Yale before dropping out, launched the original version of the company—Noetic—sometime in early 2026. The rebrand to Fuchsia came quickly, part of a broader repositioning ahead of the official YC launch. The early Launch YC post described the team as "Yale dropouts with backgrounds in frontier robotics," a bio that's been streamlined since. In April, Fuchsia exhibited at FAIR plus in Shenzhen, a signal that the company's ambitions extend beyond U.S. borders, even as those borders are drawing sharper regulatory lines.
The company has been unusually vocal about the Chinese lab crackdown. A May 16 blog post laid out the scale of the looming disruption in detail, framing Fuchsia's platform as a lifeline for manufacturers "scrambling to adapt." It's a pitch that lands with more urgency now than it might have six months ago, before the FCC vote crystallized the risk.
Still, questions linger. Can AI really absorb enough of the compliance burden to offset a tripling of lab costs? What happens when domestic labs, already stretched thin, face a sudden flood of redirected work? And will hardware founders—who tend to be cautious about mission-critical processes—trust a young startup with documentation that could make or break a product launch?
Fuchsia is betting yes. As the FCC's proposals wind through the review process, the startup finds itself at the center of a supply chain in flux, pitching automation as the antidote to regulatory upheaval. Whether that proves prescient or premature may depend less on the elegance of the AI and more on how quickly American testing labs can scale—and how willing manufacturers are to embrace new tooling when the stakes are this high.
For now, though, Gao's timing looks sharp. Almost suspiciously so.
